Google backed Isomorphic lands 2.1 billion to speed AI drug discovery toward cures

Published on 13 May 2026

Clinical trials may begin by late 2026

AI drug discovery company Isomorphic Labs has raised a staggering $2.1 billion in funding led by Thrive Capital, with support from Google-backed momentum. The fresh cash is set to expand its AI drug design engine and push timelines for early clinical testing, now expected to start by late 2026, as the company targets faster routes to treating disease.

Isomorphic Labs raised $2.1 billion led by Thrive Capital
Funding will scale its AI drug design engine
Initial clinical trials are now expected by late 2026
The company is focused on accelerating pathways to cures

#startup funding #biotech #clinical trials #ai drug discovery #isomorphic labs

Read the full story at The Economic Times

This summarization was done by Beige for a story published on The Economic Times

Google backed Isomorphic lands 2.1 billion to speed AI drug discovery toward cures

The full experience is on mobile.